{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:22:59Z","timestamp":1762507379674},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1097\/md.0000000000010490","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T19:57:33Z","timestamp":1523995053000},"page":"e0490","source":"Crossref","is-referenced-by-count":8,"title":["18F-FDG PET\/MR imaging of lymphoma nodal target lesions"],"prefix":"10.1097","volume":"97","author":[{"given":"Hanna","family":"Bernstine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liran","family":"Domachevsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meital","family":"Nidam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ifat","family":"Abadi-Korek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofer","family":"Shpilberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Groshar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-57-20210309","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/RLU.0000000000001344","article-title":"Comparison of PET\/MRI with PET\/CT in the evaluation of disease status in lymphoma","volume":"42","author":"Afaq","year":"2017","journal-title":"Clin Nucl Med"},{"key":"R2-57-20210309","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00259-017-3635-2","article-title":"18F-FDG PET\/MRI in patients suffering from lymphoma: how much MRI information is really needed?","volume":"44","author":"Kirchner","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R3-57-20210309","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00261-016-0638-6","article-title":"Hybrid FDG-PET\/MR compared to FDG-PET\/CT in adult lymphoma patients","volume":"41","author":"Atkinson","year":"2016","journal-title":"Abdom Radiol (NY"},{"key":"R4-57-20210309","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2967\/jnumed.115.166280","article-title":"Response assessment criteria and their applications in lymphoma: part 1","volume":"57","author":"Moghbel","year":"2016","journal-title":"J Nucl Med"},{"key":"R5-57-20210309","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/bjh.14734","article-title":"Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET\/CT is beneficial: a prospective multicentre trial of 355 patients","volume":"178","author":"Dann","year":"2017","journal-title":"Br J Haematol"},{"key":"R6-57-20210309","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S1470-2045(17)30103-1","article-title":"Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP (escalated) alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group","volume":"18","author":"Borchmann","year":"2017","journal-title":"Lancet Oncol"},{"key":"R7-57-20210309","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"R8-57-20210309","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/annonc\/mdw419","article-title":"ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia","volume":"27","author":"Ladetto","year":"2016","journal-title":"Ann Oncol"},{"key":"R9-57-20210309","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/annonc\/mdx097","article-title":"International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)","volume":"28","author":"Younes","year":"2017","journal-title":"Ann Oncol"},{"key":"R10-57-20210309","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2967\/jnumed.116.184242","article-title":"Response assessment criteria and their applications in lymphoma: part 2","volume":"58","author":"Moghbel","year":"2017","journal-title":"J Nucl Med"},{"key":"R11-57-20210309","doi-asserted-by":"crossref","first-page":"4729547","DOI":"10.1155\/2017\/4729547","article-title":"Meta-analysis of the correlation between apparent diffusion coefficient and standardized uptake value in malignant disease","volume":"2017","author":"Deng","year":"2017","journal-title":"Contrast Media Mol Imaging"},{"key":"R12-57-20210309","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington","year":"2014","journal-title":"J Clin Oncol"},{"key":"R13-57-20210309","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejrad.2015.12.006","article-title":"Comparison between whole-body MRI with diffusion-weighted imaging and PET\/CT in staging newly diagnosed FDG-avid lymphomas","volume":"85","author":"Albano","year":"2016","journal-title":"Eur J Radiol"},{"key":"R14-57-20210309","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.crad.2015.11.018","article-title":"Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma","volume":"71","author":"Balbo-Mussetto","year":"2016","journal-title":"Clin Radiol"},{"key":"R15-57-20210309","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/jmri.24938","article-title":"Whole-body MRI-DWI for assessment of residual disease after completion of therapy in lymphoma: a prospective multicenter study","volume":"42","author":"Littooij","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"R16-57-20210309","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1158\/1078-0432.CCR-14-2454","article-title":"Evaluation of diffusion-weighted magnetic resonance imaging for follow-up and treatment response assessment of lymphoma: results of an 18F-FDG-PET\/CT-controlled prospective study in 64 patients","volume":"21","author":"Mayerhoefer","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R17-57-20210309","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/jmri.24714","article-title":"Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: a comparison with FDG-PET\/CT","volume":"41","author":"Tsuji","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"R18-57-20210309","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiol.09090021","article-title":"Diffusion-weighted MR imaging of the liver","volume":"254","author":"Taouli","year":"2010","journal-title":"Radiology"},{"key":"R19-57-20210309","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/0284185114526087","article-title":"Diffusion-weighted MRI compared to FDG PET\/CT for assessment of early treatment response in lymphoma","volume":"56","author":"Hagtvedt","year":"2015","journal-title":"Acta Radiol"},{"key":"R20-57-20210309","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1186\/s12885-015-2009-z","article-title":"Diagnostic performance of FDG-PET\/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET\/CT","volume":"15","author":"Herrmann","year":"2015","journal-title":"BMC Cancer"},{"key":"R21-57-20210309","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2214\/AJR.10.4743","article-title":"Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET\/CT","volume":"196","author":"van Ufford","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"R22-57-20210309","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2016-05-718528","article-title":"Refinement of the Lugano classification lymphoma response criteria in the era of immunomodulatory therapy","volume":"128","author":"Cheson","year":"2016","journal-title":"Blood"},{"key":"R23-57-20210309","doi-asserted-by":"crossref","first-page":"A52","DOI":"10.1016\/j.ejrad.2017.01.023","article-title":"18F-FDG-PET\/MRI in lymphoma patients","volume":"94","author":"Ferdova","year":"2017","journal-title":"Eur J Radiol"},{"key":"R24-57-20210309","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00259-017-3690-8","article-title":"FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas","volume":"44","author":"Barrington","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R25-57-20210309","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2967\/jnumed.117.193011","article-title":"18F-FDG PET and CT-scan detect new imaging patterns of response and progression in patients with Hodgkin lymphoma treated by anti-PD1 immune checkpoint inhibitor","volume":"59","author":"Dercle","year":"2017","journal-title":"J Nucl Med"},{"key":"R26-57-20210309","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/RLU.0000000000001514","article-title":"Concordance of 18F-FDG PET uptake in tumor and normal tissues on PET\/MRI and PET\/CT","volume":"42","author":"Law","year":"2017","journal-title":"Clin Nucl Med"},{"key":"R27-57-20210309","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40644-017-0113-9","article-title":"Reproducibility and repeatability of same-day two sequential FDG PET\/MR and PET\/CT","volume":"17","author":"Groshar","year":"2017","journal-title":"Cancer Imaging"},{"key":"R28-57-20210309","doi-asserted-by":"crossref","first-page":"e4983","DOI":"10.1097\/MD.0000000000004983","article-title":"FDG PET\/CT response in diffuse large B-cell lymphoma: reader variability and association with clinical outcome","volume":"95","author":"Han","year":"2016","journal-title":"Medicine (Baltimore"},{"key":"R29-57-20210309","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2967\/jnumed.107.042093","article-title":"Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis","volume":"48","author":"Lin","year":"2007","journal-title":"J Nucl Med"},{"key":"R30-57-20210309","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2967\/jnumed.108.057703","article-title":"Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy","volume":"50","author":"Itti","year":"2009","journal-title":"J Nucl Med"},{"key":"R31-57-20210309","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/RLI.0000000000000218","article-title":"18F-Fluorodeoxyglucose positron emission tomography\/magnetic resonance in lymphoma: comparison with 18F-fluorodeoxyglucose positron emission tomography\/computed tomography and with the addition of magnetic resonance diffusion-weighted imaging","volume":"51","author":"Giraudo","year":"2016","journal-title":"Invest Radiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000010490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:04:48Z","timestamp":1620961488000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201804200-00057"}},"subtitle":["Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC)"],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":31,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000010490","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}